These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31950222)

  • 1. Enhanced anticancer activity of combined treatment of imatinib and dipyridamole in solid Ehrlich carcinoma-bearing mice.
    El-Sisi AE; Sokar SS; Ibrahim HA; Abu-Risha SE
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Jun; 393(6):1113-1129. PubMed ID: 31950222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity.
    El-Sisi AE; Sokkar SS; Ibrahim HA; Hamed MF; Abu-Risha SE
    Fundam Clin Pharmacol; 2020 Aug; 34(4):458-475. PubMed ID: 32080901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma.
    El-Ashmawy NE; Khedr EG; Ebeid EM; Salem ML; Zidan AA; Mosalam EM
    Eur J Pharm Sci; 2017 Nov; 109():525-532. PubMed ID: 28890201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronated imatinib liposomes with hybrid approach to target CD44 and P-gp overexpressing MDR cancer: an
    Negi LM; Talegaonkar S; Jaggi M; Verma AK
    J Drug Target; 2019 Feb; 27(2):183-192. PubMed ID: 29972336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of low-dose naltrexone on solid Ehrlich carcinoma in mice: The role of OGFr, BCL2, and immune response.
    Aboalsoud A; El-Ghaiesh SH; Abd Elmonem FF; Salem ML; Abdel Rahman MN
    Int Immunopharmacol; 2020 Jan; 78():106068. PubMed ID: 31835085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase inhibition boosts the antitumor effects of Imatinib mesylate via potentiating the antiangiogenic and antimetastatic machineries.
    Abd-El Fattah AA; Darwish HA; Fathy N; Shouman SA
    Toxicol Appl Pharmacol; 2017 Feb; 316():123-138. PubMed ID: 28038999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The synergistic effect between vanillin and doxorubicin in ehrlich ascites carcinoma solid tumor and MCF-7 human breast cancer cell line.
    Elsherbiny NM; Younis NN; Shaheen MA; Elseweidy MM
    Pathol Res Pract; 2016 Sep; 212(9):767-77. PubMed ID: 27493101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ursolic acid inhibits tumor angiogenesis and induces apoptosis through mitochondrial-dependent pathway in Ehrlich ascites carcinoma tumor.
    Saraswati S; Agrawal SS; Alhaider AA
    Chem Biol Interact; 2013 Nov; 206(2):153-65. PubMed ID: 24051192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ponatinib/gossypol novel combination provides enhanced anticancer activity against murine solid Ehrlich carcinoma via triggering apoptosis and inhibiting proliferation/angiogenesis.
    El-Lakkany NM; Elkattan HH; Elsisi AE
    Toxicol Appl Pharmacol; 2021 Dec; 432():115767. PubMed ID: 34699866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential cardioprotective and anticancer effects of carvedilol either free or as loaded nanoparticles with or without doxorubicin in solid Ehrlich carcinoma-bearing mice.
    Zidan A; El Saadany AA; El Maghraby GM; Abdin AA; Hedya SE
    Toxicol Appl Pharmacol; 2023 Apr; 465():116448. PubMed ID: 36921847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonist activity of the antipsychotic drug lithium chloride and the antileukemic drug imatinib mesylate during glioblastoma treatment in vitro.
    Aras Y; Erguven M; Aktas E; Yazihan N; Bilir A
    Neurol Res; 2016 Sep; 38(9):766-74. PubMed ID: 27367429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxamate potentiates taxol chemotherapeutic efficacy in experimentally-induced solid ehrlich carcinoma (SEC) in mice.
    El-Sisi AE; Sokar SS; Abu-Risha SE; El-Mahrouk SR
    Biomed Pharmacother; 2017 Nov; 95():1565-1573. PubMed ID: 28950656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic and antitumor effects of brucine on Ehrlich ascites tumor and human cancer cell line.
    Agrawal SS; Saraswati S; Mathur R; Pandey M
    Life Sci; 2011 Aug; 89(5-6):147-58. PubMed ID: 21684292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Potency of Red Seaweed (
    Wardani G; Farida N; Andayani R; Kuntoro M; Sudjarwo SA
    Pharmacognosy Res; 2017; 9(3):282-286. PubMed ID: 28827971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hesperidin on mice bearing Ehrlich solid carcinoma maintained on doxorubicin.
    Khedr NF; Khalil RM
    Tumour Biol; 2015 Dec; 36(12):9267-75. PubMed ID: 26099723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of celecoxib and its combination with imatinib on human HT-29 colorectal cancer cells: Involvement of COX-2, Caspase-3, VEGF and NF-κB genes expression.
    Atari-Hajipirloo S; Nikanfar S; Heydari A; Noori F; Kheradmand F
    Cell Mol Biol (Noisy-le-grand); 2016 Feb; 62(2):68-74. PubMed ID: 26950454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-2 treatment effect on imatinib pharmacokinetic, P-gp and BCRP expression in mice.
    Hosten B; Abbara C; Cibert M; Petit B; Farinotti R; Gonin P; Bonhomme-Faivre L
    Anticancer Drugs; 2010 Feb; 21(2):193-201. PubMed ID: 20016370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The Mechanism of Combination using mTORC1/2 Inhibitor and Imatinib to Suppress Cell Proliferation of Ph
    Wu JH; Shi FF; Gong YP; Shi R
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 48(2):216-220. PubMed ID: 28612529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sildenafil potentiates the antitumor activity of cisplatin by induction of apoptosis and inhibition of proliferation and angiogenesis.
    El-Naa MM; Othman M; Younes S
    Drug Des Devel Ther; 2016; 10():3661-3672. PubMed ID: 27895461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapy of vitamin B17 against Ehrlich solid tumor induced changes in Interferon gamma, Nuclear factor kappa B, DNA fragmentation, p53, Bcl2, survivin, VEGF and TNF-α Expressions in mice.
    El-Masry T; Al-Shaalan N; Tousson E; Buabeid M; Al-Ghadeer A
    Pak J Pharm Sci; 2020 Jan; 33(1(Supplementary)):393-401. PubMed ID: 32122873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.